Veritable’s InflaRx IFRX Stock Holding History

Veritable’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,029	Closed	-$25K	–	847
2022 Q2	$25K	Buy	+17,029	New	+$25.9K	﹤0.01%	887

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Veritable's IFRX Position: Q3 2022 in Review

Veritable sold out of InflaRx (IFRX) in Q3 2022, closing a stake of 17,029 shares — an estimated $25K sold.

Veritable first reported a position in IFRX in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 30 funds tracked by Wall St. Rank hold IFRX as of Q3 2022.

Veritable reported no remaining InflaRx position as of Q3 2022 after selling out during the quarter.
Veritable sold 17,029 InflaRx shares in Q3 2022, an estimated $25K.
Veritable first reported a position in InflaRx in Q2 2022 and held it in 1 quarter.
Veritable's InflaRx position peaked at $25K in Q2 2022.
30 funds tracked by Wall St. Rank held InflaRx as of Q3 2022.

Based on Veritable's 13F filing for Q3 2022, filed 14 Nov 2022.